169 related articles for article (PubMed ID: 10585526)
1. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices.
Lue WM; Su MT; Lin WB; Tao PL
Eur J Pharmacol; 1999 Oct; 383(2):129-35. PubMed ID: 10585526
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
[TBL] [Abstract][Full Text] [Related]
3. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
Elliott K; Minami N; Kolesnikov YA; Pasternak GW; Inturrisi CE
Pain; 1994 Jan; 56(1):69-75. PubMed ID: 7512709
[TBL] [Abstract][Full Text] [Related]
4. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
Elliott K; Kest B; Man A; Kao B; Inturrisi CE
Neuropsychopharmacology; 1995 Dec; 13(4):347-56. PubMed ID: 8747759
[TBL] [Abstract][Full Text] [Related]
6. Study the mechanisms of U-50,488 to prevent the development of morphine tolerance in guinea pigs.
Tao PL; Wu SC; Yang CH; Wu CC
Chin J Physiol; 2000 Dec; 43(4):179-84. PubMed ID: 11292183
[TBL] [Abstract][Full Text] [Related]
7. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
8. The role of vasopressin on the effect of U-50,488 to block the development of morphine tolerance and physical dependence.
Tao PL; Liu WC; Tsuei YS; Cheng CY
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):281-7. PubMed ID: 9050024
[TBL] [Abstract][Full Text] [Related]
9. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
[TBL] [Abstract][Full Text] [Related]
10. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
11. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
12. Lack of morphine and enkephalin tolerance in 129/SvEv mice: evidence for a NMDA receptor defect.
Kolesnikov Y; Jain S; Wilson R; Pasternak GW
J Pharmacol Exp Ther; 1998 Feb; 284(2):455-9. PubMed ID: 9454784
[TBL] [Abstract][Full Text] [Related]
13. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
Wong CS; Hsu MM; Chou YY; Tao PL; Tung CS
Br J Anaesth; 2000 Oct; 85(4):587-91. PubMed ID: 11064618
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.
Pasternak GW; Kolesnikov YA; Babey AM
Neuropsychopharmacology; 1995 Dec; 13(4):309-13. PubMed ID: 8747755
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat.
Shim I; Kim HT; Kim YH; Chun BG; Hahm DH; Lee EH; Kim SE; Lee HJ
Eur J Pharmacol; 2002 May; 443(1-3):119-24. PubMed ID: 12044801
[TBL] [Abstract][Full Text] [Related]
16. Sedative but not analgesic alpha2 agonist tolerance is blocked by NMDA receptor and nitric oxide synthase inhibitors.
Davies MF; Reid K; Guo TZ; Agashe GS; Amin YK; Maze M
Anesthesiology; 2001 Jul; 95(1):184-91. PubMed ID: 11465557
[TBL] [Abstract][Full Text] [Related]
17. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception.
Kest B; Marek P; Liebeskind JC
Brain Res; 1992 Aug; 589(1):139-42. PubMed ID: 1422813
[TBL] [Abstract][Full Text] [Related]
18. Prevention by morphine of N-methyl-D-aspartic acid-induced penile erection and yawning: involvement of nitric oxide.
Melis MR; Succu S; Argiolas A
Brain Res Bull; 1997; 44(6):689-94. PubMed ID: 9421131
[TBL] [Abstract][Full Text] [Related]
19. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material.
Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F
Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079
[TBL] [Abstract][Full Text] [Related]
20. Effects of various nitric oxide synthase inhibitors on NMDA-induced neuronal injury in rat cortical neurons.
Wang JY; Chi SI; Wang JY; Hwang CP; Wang JY
Chin J Physiol; 1996; 39(4):227-33. PubMed ID: 9058007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
